Skip to main content

Advertisement

Log in

Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Background

Recent data indicate that among patients undergoing percutaneous coronary intervention low platelet response to aspirin is associated with clopidogrel low response. It is unclear whether these findings extend to other patient populations. We, therefore, aimed to evaluate the relation between response to aspirin and clopidogrel among patients scheduled to undergo cardiac or vascular surgery.

Methods

Patients who were scheduled for cardiac or vascular surgery and had taken aspirin 81–325 mg daily for at least a week and clopidogrel 75 mg daily for at least 3 days underwent blood testing for platelet function. One hundred patients were included in the current analysis. Platelet function was evaluated by the modified TEG platelet mapping assay with addition of ADP or arachidonic acid (AA), and by the PFA-100 assay with collagen-epinephrine (CEPI) or collagen-ADP (CADP) cartridges. Low response to aspirin or clopidogrel was defined as inhibition ≤20% for TEG-AA or TEG-ADP, respectively.

Results

Thirteen patients (13%) were low responders to aspirin and 34 (34%) were low responders to clopidogrel. Eight patients were low responders to both drugs. There were no differences in clinical characteristics between drug low responders versus sensitive patients. Aspirin low responders had lower TEG-ADP inhibition (19.5 ± 6 vs. 35.8 ± 3%, P = 0.03) and tended to have lower PFA-CADP time (84.7 ± 7 vs. 105.6 ± 5 s, P = 0.1) than aspirin sensitive patients. Clopidogrel low responders had lower TEG-AA inhibition (58 ± 6 vs. 75.1 ± 4%, P = 0.01) and PFA-CEPI time (168 ± 13 vs. 200.4 ± 10 s, P = 0.07) than clopidogrel sensitive patients.

Conclusions

In patients scheduled to undergo cardiovascular surgery low response to aspirin is associated with low response to clopidogrel.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Buchanan MR, Brister SJ (1995) Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 11:221–227

    PubMed  CAS  Google Scholar 

  2. Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S (2002) Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105:1650–1655

    Article  PubMed  CAS  Google Scholar 

  3. Gurbel PA, Bliden KP, Hiatt BL, O’Connor CM (2003) Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107:2908–2913

    Article  PubMed  Google Scholar 

  4. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ (2005) Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 45:246–251

    Article  PubMed  CAS  Google Scholar 

  5. Lev E, Patel RT, Maresh KJ et al (2006) Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47:27–33

    Article  PubMed  CAS  Google Scholar 

  6. Cuisset T, Frere C, Quilici J et al (2006) High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome. J Thromb Haemost 4:542–549

    Article  PubMed  CAS  Google Scholar 

  7. Craft RM, Chavez JJ, Bresee SJ, Wortham DC, Cohen E, Carroll RC (2004) A novel modification of the thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 143:301–309

    Article  PubMed  Google Scholar 

  8. Craft RM, Chavez JJ, Snider CC, Muenchen RA, Carroll RC (2005) Comparison of modified thrombelastograph and plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients. J Lab Clin Med 145:309–315

    Article  PubMed  CAS  Google Scholar 

  9. Fontana P, Nolli S, Reber G, de Moerloose P (2006) Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 heal hy volunteers. J Thromb Haemost 4:813–819

    Article  PubMed  CAS  Google Scholar 

  10. Eikelboom JW, Hankey GJ et al (2005) Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 3:2649–2655

    Article  PubMed  CAS  Google Scholar 

  11. Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD (2001) Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behavior between unstable angina and myocardial infarction. Thromb Haemost 85:989–994

    PubMed  CAS  Google Scholar 

  12. Harrison P, Mackie I, Mathur A et al (2005) Platelet hyper-function in acute coronary syndromes. Blood Coagul Fibrinolysis 16:557–562

    Article  PubMed  CAS  Google Scholar 

  13. Coulter SA, Cannon CP, Ault KA et al (2000) High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. Circulation 101:2690–2695

    PubMed  CAS  Google Scholar 

  14. Macchi L, Christiaens L, Brabant S et al (2002) Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res 107:45–49

    Article  PubMed  CAS  Google Scholar 

  15. Kawasaki T, Ozeki Y, Igawa T, Kambayashi J (2000) Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin. Stroke 31:591–595

    PubMed  CAS  Google Scholar 

  16. Guthikonda S, Lev EI, Patel R et al (2006) Aspirin resistance is strongly associated with increased platelet turnover. J Thromb Haemost (in press)

  17. Szczeklik A, Undas A, Sanak M, Frolow M, Wegrzyn W (2000) Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Br J Haematol 110:965–967

    Article  PubMed  CAS  Google Scholar 

  18. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E et al (2004) PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation. Blood Coagul Fibrinolysis 15:89–93

    Article  PubMed  Google Scholar 

  19. Tantry US, Bliden KP, Gurbel PA (2005) Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 46:1705–1709

    Article  PubMed  CAS  Google Scholar 

  20. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41:961–965

    Article  PubMed  CAS  Google Scholar 

  21. Matetzky S, Shenkman B, Guetta V et al (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulatio 109:3171–3175

    Article  CAS  Google Scholar 

  22. Muller I, Besta F, Schulz C, Massberg S, Schonig A, Gawaz M (2003) Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89:783–787

    PubMed  CAS  Google Scholar 

  23. Chen WH, Lee PY, Ng W, Tse HF, Lau CP (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43:1122–1126

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neal S. Kleiman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lev, E.I., Ramchandani, M., Garg, R. et al. Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery. J Thromb Thrombolysis 24, 15–21 (2007). https://doi.org/10.1007/s11239-007-0008-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-007-0008-x

Keywords

Navigation